cancer clinical trials in charlottesville, VA
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Lymphoma
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Breast Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Head and Neck Cancer, Oral Complications, Radiation Toxicity
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Leukemia
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Pancreatic Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Endometrial Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
|
University of Virginia Cancer Center at UV Health System
Charlottesville, Virginia 22908 Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Brain and Central Nervous System Tumors
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Lymphoma
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Leukemia
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Colorectal Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Sarcoma
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Sarcoma
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Colorectal Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Endometrial Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Lymphoma
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Pancreatic Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Prostate Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Brain and Central Nervous System Tumors
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Extrahepatic Bile Duct Cancer, Liver Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Metastatic Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Sarcoma
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Lymphoma
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Lung Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Lung Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Colorectal Cancer, Neoplasm Metastasis
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Cervical Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Lung Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Cervical Cancer
|
Martha Jefferson Hospital Cancer Care Center
Charlottesville, Virginia 22901 Lung Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Breast Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Leukemia, Myelodysplastic Syndromes
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Carcinoma of Unknown Primary
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Colorectal Cancer, Diarrhea, Neutropenia
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Ovarian Cancer
|
Hematology Oncology Patient Enterprises, Center for Cancer Care
Charlottesville, Virginia 22902 Non-small Cell Lung Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Prostate Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Malignant Mesothelioma
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Leukemia
|
Martha Jefferson Hospital Cancer Care Center
Charlottesville, Virginia 22901 Pancreatic Cancer
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Breast Cancer
|
University of Virginia Cancer Center at UV Health System
Charlottesville, Virginia 22908 Cervical Cancer
|
University of Virginia Medical Center
Charlottesville, Virginia 22908 Non-Hodgkin's Lymphoma
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Lung Cancer
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
|
University of Virginia
Charlottesville, Virginia 22908 Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
|
Martha Jefferson Hospital Cancer Care Center
Charlottesville, Virginia 22901 Pancreatic Cancer
|
Univ. of Virginia Health System-Cancer Center Clinical Trials Office
Charlottesville, Virginia 22908 Non-Hodgkin's Lymphoma
|
Pain Management Center, University of Virginia
Charlottesville, Virginia 22903 Pain
|
University of Virginia Health Systems - Department of Neurological Surgery
Charlottesville, Virginia 22908 Glioblastoma Multiforme
|
Martha Jefferson Hospital
Charlottesville, Virginia 22901 Colorectal Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Lung Cancer
|
University of Virginia
Charlottesville, Virginia 22908 Carcinoma, Hepatocellular
|
Cancer Center at the University of Virginia
Charlottesville, Virginia 22908 Endometrial Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Lymphoma
|
University of Virginia Health Systems - Department of Neurological Surgery
Charlottesville, Virginia 22908 Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma
|
University of Virginia Health System
Charlottesville, Virginia 22903 Glioblastoma Multiforme
|
University of Virginia
Charlottesville, Virginia 22908 Cirrhosis, Hepatitis C, Hepatocellular Carcinoma
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Sarcoma
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Lymphoma
|
University of Virginia Health System
Charlottesville, Virginia 22903 Prostate Cancer
|
University of Virginia Cancer Center at UV Health System
Charlottesville, Virginia 22908 Head and Neck Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Lung Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Metastatic Cancer
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Sarcoma
|
University of Virginia Cancer Center
Charlottesville, Virginia 22908 Breast Cancer, Osteoporosis
|
University of Virginia
Charlottesville, Virginia 22908 Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
|
University of Virgina Cancer Center, UVA Division of Hematology & Oncology
Charlottesville, Virginia 22908 Leukemia, Myeloid, Chronic Phase
|